News Trump's DOJ reschedules medicinal marijuana, increasing acce... The US Justice Department has issued an order moving medical marijuana to Schedule III, removing some barriers to access for patients and researchers.
R&D The evolving landscape of medicinal cannabis and its synergy... The journey of medicinal cannabis has seen remarkable adoption worldwide.
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.